At a glance
ClinicalIndex Comparison RecordN/ACompleted· 258 enrolled
Drug / intervention
Total Plaque Volumeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
In Brief
An observational study evaluating Total Plaque Volume for Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)). Completed, enrolled 258 participants across 1 site.
Detailed Summary
This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedNov 2021
Primary CompletionNov 2022
TodayJul 2026
First PostedNov 30, 2021
Enrollment StartOct 12, 2021
Primary CompletionNov 8, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.6 years ago
Interventions
Total Plaque Volumeother
Compare total plaque volume with IVUS obtained during ICA (invasive coronary angiography)